Press "Enter" to skip to content

Serum Institute Doing Best to Ramp Up Covid-19 Vaccine Production, Says Adar Poonawalla

File photograph of Serum Institute of India CEO Adar Poonawalla.

Poonawalla was responding to a tweet by JSW Group Chairman Sajjan Jindal.

  • PTI New Delhi
  • Last Updated:May 15, 2021, 23:37 IST
  • FOLLOW US ON:

Serum Institute of India (SII) is doing its greatest to ramp up the manufacturing of COVID-19 vaccine Covishield to cater to demand within the nation, Adar Poonawalla mentioned on Saturday. Responding to a tweet by JSW Group Chairman Sajjan Jindal, Poonawalla mentioned the vaccine main is doing its greatest to introduce vaccines on precedence for the Indian market.

“Yes@sajjanjindal, we at @SerumInstIndia are doing our greatest to ramp up manufacturing & launch new vaccines on precedence for India. We are grateful for @TheJSWGroup efforts in making an attempt to satisfy India’s medical oxygen wants as we stand collectively on this struggle towards this pandemic,”Poonawalla mentioned in a tweet.

Earlier Sajjan Jindal had tweeted whereas tagging SII, Poonawalla , Bharat Biotech and its Managing Director Krishna Ella: “The solely manner we are able to win the #FightAgainstCOVID19in India is to vaccinate all people. Great to see @SerumInstIndia @adarpoonawalla and @BharatBiotech @krishnaella ramping up their capacities.

Both SII and Bharat Biotech are within the forefront of supplying COVID-19 vaccines within the nation even because the second wave of the pandemic continues to ravage varied states.

Read all of the Latest News, Breaking News and Coronavirus News right here

Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    %d bloggers like this: